Rakesh Jhunjhunwala is called India’s most successful investor. There is a craze in the investor community to buy into stocks in which he has a stake. The recent correction in the markets has taken Nifty close to its 200DMA. The 200DMA is often reckoned the strongest support level of a bull run. As such, at the current levels there is an opportunity to buy. In this article we list out some of the best picks of Rakesh Jhunjhunwala which investors can buy in this correction.
Rakesh Jhunjhunwala has 8 crore shares of Titan, which constitute 9.05% of the total market capital of Titan Company. Rakesh Jhunjhunwala’s first brought in 2002-03 at an average price of Rs.5. The stock then rose to touch Rs 80 but later fell to Rs 30. The big bull had long term plans and did not sell a single share. Today, the stock hovers around Rs.400. Historically; Titan has always given good returns over the years. Fundamentals of the company are strong. In the last decade Titan has revolutionized the jewellery and watch segment by bringing class and style into the jewellery and watch segment. Titan is one of the very few world class brands that have been made in India. Titan is India’s largest manufacturer of quartz watches and has a dominant 60% market share in the Indian market. It is the world’s sixth largest manufacturer of branded watches. It has successful brands like Fastrack, Nebula, Sonata, Titan Raga and Octane. Titan also has the rights for the marketing and distribution of Tommy Hilfiger and Hugo Boss watches. Speaking about Titan, Rakesh Jhunjhunwala said that India would grow at 7 and 8 per cent and that demand for FMCG and consumer durables would see strong growth. As per Rakesh Jhunjhunwala the current Rs.45000 crore Indian jewellery market was roughly Rs 45,000 crore would see enormous growth in the years to come. Titan having 55 to 60 per cent market share of India’s organized watch market is bound to prosper supported by its jewellery business.
The Second largest holding in Rakesh Jhunjhunwala’s portfolio is Lupin. Rakesh Jhunjhunwala started investing in this stock when it was trading at around Rs. 49. Currently, he has around 80 lakhs shares which comprise 1.76% of Lupin shares. His investment in Lupin has a market capitalisation close to 700 crore. He has been holding the stock for the last 11 years. At the current market price of 1750 the return has been more than 1000% after adjusting for bonus and split. Lupin has presence in more than 70 countries. The company is engaged in the development of the APIs, generic and branded formulations. Lupin is the largest manufacturer of Tuberculosis drugs in the world. It has remained one of the country’s top Pharma companies over the years. The company has done great work in research and development. It has been successful in new product launches and has been very aggressive in entering into new geographies. It has an advanced biotechnology program and expanded Novel Drug Discovery and Development pipeline to grab future opportunities. Lupin has been a great stock for the long term investors over the years and still making new highs.
CRISIL is at Number third position in Rakesh Jhunjhunwala’s portfolio as far as weightage is concerned. Currently he is holding 40 lakhs shares of CRISIL which has a valuation of Rs.444 crore. His holding is around 5.67% of the share capital of CRISIL. The stock has been a part of Jhunjhunwala’s portfolio for a long time. Currently the market capitalisation of his investment is 6,532 crore. Crisil continues to be a good performer investments in the stock ensure good returns in the long run. The company is India's leading ratings agency. It provides high-end research to some of the world's largest banks and leading corporations. Its majority shareholder is Standard & Poor’s, one of the world's foremost rating provider of independent credit rating, risk evaluation and investment research. The company operates in three segments - Ratings, Research and Advisory. Over the years, the company has rated more than 60,000 entities in the country.